![Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.351.issue-2/nejmoa032975/production/images/img_medium/nejmoa032975_t2.jpeg)
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy | NEJM
![Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population](https://static-02.hindawi.com/articles/pc/volume-2020/3964615/figures/3964615.fig.001e.jpg)
Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
![Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening - ScienceDirect Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429521005392-gr1.jpg)
Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening - ScienceDirect
![Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/319485368/figure/fig1/AS:540342232588289@1505839035992/Prebiopsy-mpMRI-of-a-65-year-old-patient-PSA-level-582-ng-mL-a-Transverse-T.png)
Prebiopsy mpMRI of a 65-year-old patient (PSA level 5.82 ng/mL). (a)... | Download Scientific Diagram
![PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/251be2484ab726805c25860ba5917364701380f4/2-Table1-1.png)
PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar
![Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram](https://www.researchgate.net/publication/333111204/figure/tbl1/AS:758814324305920@1557926841247/Change-in-PsA-Disk-score-across-different-rheumatological-variables-in-patients-with-PsA.png)
Change in PsA-Disk score across different rheumatological variables in... | Download Scientific Diagram
Supplementary Table 5 Correlation of AR with serum PSA levels Correlation coefficient P-value AR (IHC) 0.06 (81) 0.578 pAR 0.31
![A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1748-717X-8-170/MediaObjects/13014_2013_Article_893_Fig2_HTML.jpg)
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text
![Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l | Journal of Urology Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l | Journal of Urology](https://www.auajournals.org/cms/asset/a69b46f8-cfb3-4da1-9770-63a65b5b9764/si1.gif)